Catalyst
Slingshot members are tracking this event:
Genfit (GNFT) Phase 2 program targeting fibrosis and cirrhosis plans to submit IND application in second half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 03, 2018
Occurred Source:
https://globenewswire.com/news-release/2018/12/03/1660476/0/en/GENFIT-Launch-of-a-U-S-Phase-2-investigator-initiated-study-with-nitazoxanide-in-patients-with-NASH-induced-fibrosis.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cirrhosis, Fibrosis, Ind Filing, Phase 2
